These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Coronary Plaque Characterization in Psoriasis Reveals High-Risk Features That Improve After Treatment in a Prospective Observational Study. Lerman JB; Joshi AA; Chaturvedi A; Aberra TM; Dey AK; Rodante JA; Salahuddin T; Chung JH; Rana A; Teague HL; Wu JJ; Playford MP; Lockshin BA; Chen MY; Sandfort V; Bluemke DA; Mehta NN Circulation; 2017 Jul; 136(3):263-276. PubMed ID: 28483812 [TBL] [Abstract][Full Text] [Related]
4. Estimated sdLDL-C for predicting high-risk coronary plaque features in psoriasis: a prospective observational study. Sorokin AV; Patel N; Li H; Hong CG; Sampson M; O'Hagan R; Florida EM; Teague HL; Playford MP; Chen MY; Mehta NN; Remaley AT Lipids Health Dis; 2023 Apr; 22(1):55. PubMed ID: 37106374 [TBL] [Abstract][Full Text] [Related]
5. Association of oxidized ApoB and oxidized ApoA-I with high-risk coronary plaque features in cardiovascular disease. Sorokin AV; Hong CG; Aponte AM; Florida EM; Tang J; Patel N; Baranova IN; Li H; Parel PM; Chen V; Wilson SR; Ongstad EL; Collén A; Playford MP; Eggerman TL; Chen MY; Kotani K; Bocharov AV; Remaley AT JCI Insight; 2023 Oct; 8(20):. PubMed ID: 37698922 [TBL] [Abstract][Full Text] [Related]
6. Relationship of Soluble Lectin-Like Low-Density Lipoprotein Receptor-1 (sLOX-1) With Inflammation and Coronary Plaque Progression in Psoriasis. Florida EM; Li H; Hong CG; Ongstad EL; Gaddipati R; Sitaula S; Varma V; Parel PM; O'Hagan R; Chen MY; Teague HL; Playford MP; Karathanasis SK; Collén A; Mehta NN; Remaley AT; Sorokin AV J Am Heart Assoc; 2023 Nov; 12(22):e031227. PubMed ID: 37982276 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the atherogenic tendency of lipids and lipoprotein content and their relationships with oxidant-antioxidant system in patients with psoriasis. Vanizor Kural B; Orem A; Cimşit G; Yandi YE; Calapoglu M Clin Chim Acta; 2003 Feb; 328(1-2):71-82. PubMed ID: 12559600 [TBL] [Abstract][Full Text] [Related]
8. Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study. Coimbra S; Oliveira H; Reis F; Belo L; Rocha S; Quintanilha A; Figueiredo A; Teixeira F; Castro E; Rocha-Pereira P; Santos-Silva A Am J Clin Dermatol; 2010 Dec; 11(6):423-32. PubMed ID: 20429617 [TBL] [Abstract][Full Text] [Related]
9. Cholesterol efflux capacity in humans with psoriasis is inversely related to non-calcified burden of coronary atherosclerosis. Salahuddin T; Natarajan B; Playford MP; Joshi AA; Teague H; Masmoudi Y; Selwaness M; Chen MY; Bluemke DA; Mehta NN Eur Heart J; 2015 Oct; 36(39):2662-5. PubMed ID: 26188212 [TBL] [Abstract][Full Text] [Related]
11. Higher oxidized high-density lipoprotein to apolipoprotein A-I ratio is associated with high-risk coronary plaque characteristics determined by CT angiography. Suruga K; Miyoshi T; Kotani K; Ichikawa K; Miki T; Osawa K; Ejiri K; Toda H; Nakamura K; Morita H; Ito H Int J Cardiol; 2021 Feb; 324():193-198. PubMed ID: 32987049 [TBL] [Abstract][Full Text] [Related]
12. The relationship between systemic inflammation and increased left ventricular mass is partly mediated by noncalcified coronary artery disease burden in psoriasis. Zhou W; Teklu M; Bui V; Manyak GA; Kapoor P; Dey AK; Sorokin AV; Patel N; Teague HL; Playford MP; Erb-Alvarez J; Rodante JA; Keel A; Shanbhag SM; Hsu LY; Bluemke DA; Chen MY; Carlsson M; Mehta NN Am J Prev Cardiol; 2021 Sep; 7():100211. PubMed ID: 34611643 [TBL] [Abstract][Full Text] [Related]
13. Effect of tofacitinib on lipid levels and lipid-related parameters in patients with moderate to severe psoriasis. Wolk R; Armstrong EJ; Hansen PR; Thiers B; Lan S; Tallman AM; Kaur M; Tatulych S J Clin Lipidol; 2017; 11(5):1243-1256. PubMed ID: 28751001 [TBL] [Abstract][Full Text] [Related]
14. Abnormal lipoprotein particles and cholesterol efflux capacity in patients with psoriasis. Mehta NN; Li R; Krishnamoorthy P; Yu Y; Farver W; Rodrigues A; Raper A; Wilcox M; Baer A; DerOhannesian S; Wolfe M; Reilly MP; Rader DJ; VanVoorhees A; Gelfand JM Atherosclerosis; 2012 Sep; 224(1):218-21. PubMed ID: 22858285 [TBL] [Abstract][Full Text] [Related]
15. The Relationship between Circulating APOA-1 and Atherosclerosis Initiation and Progression in Psoriasis. Teague HL; Li H; Berg AR; Hong C; Petrole RF; O'Hagan R; Florida EM; Keel A; Rodante J; Kapoor P; Gonzalez-Cantero A; Sorokin AV; Joshi A; Patel N; Gelfand JM; Playford MP; Mehta NN J Invest Dermatol; 2023 Oct; 143(10):1947-1954.e4. PubMed ID: 37088280 [TBL] [Abstract][Full Text] [Related]